SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-028536
Filing Date
2014-01-30
Accepted
2014-01-30 16:32:00
Documents
3
Period of Report
2014-01-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d666251d8k.htm 8-K 16401
2 EX-99.1 d666251dex991.htm EX-99.1 12501
3 GRAPHIC g666251g02e87.jpg GRAPHIC 30157
  Complete submission text file 0001193125-14-028536.txt   71765
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 14561138
SIC: 2836 Biological Products, (No Diagnostic Substances)